Company: LBRX
Filing Date: 2025-08-22
Form Type: S-1
Source: 0001193125-25-186467
Chunk: 369

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-08-22
Form: S-1
Chunk 369
---
 issuance of stock options or restricted stock up to 0.8 million shares of the Company’s common stock. In August 2018, the Company amended the 2017 Plan, reducing the maximum aggregate number of shares that may be issued under the 2017 Plan to 0.6 million. No additional awards will be granted under the 2017 Plan. As of both December 31, 2024 and 2023, there were 0.3 million shares outstanding under the 2017 Plan. In 2018, the Company’s Board of Directors approved the LB Pharmaceuticals Inc 2018 Stock Incentive Plan (“2018 Plan”). The 2018 Plan authorized the issuance of stock options or restricted stock up to 1.1 million shares of the Company’s common stock. No additional awards will be granted under the 2018 Plan. As of both December 31, 2024 and 2023, there were 0.8 million shares outstanding under the 2018 Plan. In August 2023, the Company’s Board of Directors approved the LB Pharmaceuticals Inc 2023 Stock Incentive Plan, as amended (“2023 Plan”). The 2023 Plan authorized the issuance of stock options or restricted stock up to 8.1 million shares of the Company’s common stock. In December 2024, the Company amended the 2023 Plan increasing the maximum aggregate number of shares that may be issued under the 2023 Plan to approximately 13.0 million. The 2023 Plan expires in August 2033. As of December 31, 2024 and 2023, there were 11.7 million and 2.5 million shares outstanding, respectively. As of December 31, 2024, there are 1.3 million shares available for future issuance under the 2023 Plan. Stock Options Stock options vest based on one of the following schedules: (i) 25% on the first anniversary of grant date with the remaining 75% to vest in 36 equal monthly installments thereafter through the fourth anniversary of the grant date; (ii) 100% vesting in 36 equal monthly installments through the third anniversary of the grant date; or (iii) 100% vesting in 12 equal monthly installments through the first anniversary of the grant date for certain nonemployee grants. All stock options expire ten years from the grant date. The assumptions used to determine the fair value of stock options granted to employees and